Manmeet Singh Soni's Net Worth

$73.6 Million

Estimate Recalculated Sep 13, 2024 06:31PM EST

Who is Manmeet Singh Soni?

Manmeet Singh Soni has an estimated net worth of $73.6 Million. This is based on reported shares across multiple companies, which include ALNYLAM PHARMACEUTICALS, INC., ARENA PHARMACEUTICALS INC, REATA PHARMACEUTICALS INC, Summit Therapeutics Inc., PULSE BIOSCIENCES, INC., ARIAD PHARMACEUTICALS INC, and PHARMACYCLICS INC.

SEC CIK

Manmeet Singh Soni's CIK is 0001569769

Past Insider Trading and Trends

2023 was Manmeet Singh Soni's most active year for acquiring shares with 13 total transactions. Manmeet Singh Soni's most active month to acquire stocks was the month of December. 2023 was Manmeet Singh Soni's most active year for disposing of shares, totalling 27 transactions. Manmeet Singh Soni's most active month to dispose stocks was the month of May. 2023 saw Manmeet Singh Soni paying a total of $11,135,499.20 for 17,506,178 shares, this is the most they've acquired in one year. In 2015 Manmeet Singh Soni cashed out on 201,971 shares for a total of $21,890,954.27, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ALNYLAM PHARMACEUTICALS, INC. (ALNY) Snapshot price: $246.78

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 28
Form 4
∞
83
—
—
83
Jul 25 - Aug 13
Form 4
—
0
—
—
0
Mar 1
Form 3
—
0
—
—
0
No matching records found

ARENA PHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-4.90%
-304.00
$62.74
-$19,072.96
5.9K
Scheduled
Jun 17
Form 4
+22.00%
1.12K
$60.12
-$79,779.24
6.21K
Scheduled
Jun 12 - Jun 15
Form 4
+39.37%
1.44K
$55.89
-$68,021.89
5.09K
Scheduled
Jun 13 - Jun 14
Form 4
∞
3.65K
—
—
3.65K
Dec 14
Form 3
—
0
—
—
0
No matching records found

REATA PHARMACEUTICALS INC No price found

COO, CFO and President

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-62.62K
—
—
0
Sep 26
Form 4
-2.73%
-1.75K
$168.41
-$295,565.69
62.62K
Aug 16
Form 4
—
0
$164.62
-$12,346,297.50
64.38K
Jul 28
Form 4
+10.28%
6K
—
—
64.38K
Jul 6
Form 4
-49.75%
-57.80K
$65.02
-$7,820,639.95
58.38K
Jun 12 - Jun 13
Form 4
-16.00%
-22.13K
$84.45
-$1,869,150.48
116.17K
May 15 - May 16
Form 4
+56.62%
50K
—
—
138.3K
May 5
Form 4
-0.70%
-622.00
$84.70
-$52,680.29
88.3K
Mar 7
Form 4
-3.88%
-3.59K
$87.97
-$315,548.39
88.93K
Mar 3
Form 4
—
0
—
—
0
Feb 28
Form 4
+34.08%
23.51K
—
—
92.51K
Jan 3
Form 4
+263.16%
50K
—
—
69K
Jan 3
Form 4
+533.33%
16K
$26.22
$419,564.80
19K
Dec 31
Form 4
—
0
—
—
0
Jan 4
Form 4
∞
3K
$100.21
$300,630.00
3K
Aug 14
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Aug 28
Form 3
—
0
—
—
0
No matching records found

Summit Therapeutics Inc. (SMMT) Snapshot price: $12.2

COO and CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+1.48%
44.05K
$22.70
$999,980.40
3.02M
Sep 11
Form 4
—
0
—
—
0
Aug 23
Form 4
—
0
—
—
0
Apr 2
Form 4
∞
2.98M
$1.68
$4,999,999.20
2.98M
Oct 13
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
—
—
0
Feb 19
Form 3
—
0
—
—
0
No matching records found

PULSE BIOSCIENCES, INC. (PLSE) Snapshot price: $17.19

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Aug 9
Form 4
—
0
—
—
0
Jun 6
Form 4
—
0
—
—
0
May 25
Form 4
—
0
—
—
0
May 19
Form 4
—
0
—
—
0
May 20
Form 4
—
0
—
—
0
May 18
Form 4
—
0
—
—
0
May 16
Form 4
—
0
—
—
0
Jan 7
Form 4
—
0
—
—
0
May 23
Form 4
—
0
—
—
0
Nov 2
Form 3
—
0
—
—
0
No matching records found